HealthUnlocked

Redirect Notice

Looks like you clickedhttps://www.globenewswire.com/news-release/2019/06/15/1869291/0/en/Sunesis-Pharmaceuticals-Announces-Presentation-of-Preliminary-Data-from-Phase-1b-2-Trial-of-Vecabrutinib-in-Patients-with-CLL-and-Other-B-Cell-Malignancies-at-EHA-Annual-Meeting.html

If you do not want to visit that page, you can close this browser tab.